We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia

Product News   Feb 23, 2011

 
Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Formedix Announces Expansion to Meet Demands for Clinical Trial Automation

Product News

Formedix, announces expansion of its development and test teams. By expanding the workforce, Formedix can stay abreast of technological breakthroughs and meet greater client demands for the enhancement and advancement of its platform.

READ MORE

Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment

Product News

Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion for an Orphan Drug Designation (ODD) status to its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer.

READ MORE

REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients

Product News

Regeneron has announced the first data from a descriptive analysis of a Phase 1/2/3 trial of the investigational antibody cocktail known as "REGN-COV2". Results show that it reduced viral load and alleviated symptoms in non-hospitalized patients with COVID-19.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE